Updated FDA Recognition of CLSI Breakpoints (JCM ed.)
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Updated FDA Recognition of CLSI Breakpoints (JCM ed.)
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Oversight and guidance for performing antibiotic susceptibility testing can be bewildering. There is an alphabet soup of agencies and bodies involved: FDA, CLSI, and USCAST, to name a few here in the US. How does the Food and Drug Administration, which has regulatory authority over AST, work with a nimble group like the Clinical Laboratory Standards Institute?
Guests:
- Romney Humphries, Ph.D., D(ABMM), M(ASCP)
- Patricia Simner, Ph.D., D(ABMM)
- Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance
- Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals.
- Attend ASM Microbe
This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro.
Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.
Follow JCM on Twitter/𝕏 via @JClinMicro
Pas encore de commentaire